Nuvalent (NUVL) Total Liabilities (2020 - 2026)
Nuvalent (NUVL) posted Total Liabilities of $156.8 million for Q1 2026, down 4.61% on a QoQ basis from $164.4 million in Q4 2025, and up 65.47% year-over-year from $94.7 million in Q1 2025.
Nuvalent (NUVL) Total Liabilities (2020 - 2026) Analysis & Trends
Nuvalent's Total Liabilities history runs 7 years deep, the most recent figure standing at $156.8 million for Q1 2026.
- Quarterly Total Liabilities rose 65.47% year-over-year to $156.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $156.8 million (up 65.47% YoY) and the FY2025 annual result came in at $164.4 million, up 128.41% from the prior year.
- Total Liabilities was $156.8 million for Q1 2026 at Nuvalent, down from $164.4 million in the prior quarter.
- Across five years, Total Liabilities topped out at $164.4 million in Q4 2025 and bottomed at $8.1 million in Q1 2022.
- A 5-year average of $59.5 million and a median of $33.4 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2023 — Total Liabilities surged 63.35% — and 2025, when it surged 183.45%.
- Nuvalent's Total Liabilities stood at $19.5 million in 2022, then jumped by 63.35% to $31.8 million in 2023, then jumped by 126.13% to $72.0 million in 2024, then surged by 128.41% to $164.4 million in 2025, then dropped by 4.61% to $156.8 million in 2026.
- Business Quant data shows NUVL's Total Liabilities at $156.8 million in Q1 2026, $164.4 million in Q4 2025, and $134.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | 156.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 156.78 Mn |
| Dec 31, 2025 | 164.37 Mn |
| Sep 30, 2025 | 134.51 Mn |
| Jun 30, 2025 | 100.80 Mn |
| Mar 31, 2025 | 94.75 Mn |
| Dec 31, 2024 | 71.96 Mn |
| Sep 30, 2024 | 67.73 Mn |
| Jun 30, 2024 | 38.19 Mn |
| Mar 31, 2024 | 33.43 Mn |
| Dec 31, 2023 | 31.82 Mn |
| Sep 30, 2023 | 29.10 Mn |
| Jun 30, 2023 | 20.80 Mn |
| Mar 31, 2023 | 17.02 Mn |
| Dec 31, 2022 | 19.48 Mn |
| Sep 30, 2022 | 12.98 Mn |
| Jun 30, 2022 | 10.04 Mn |
| Mar 31, 2022 | 8.12 Mn |
| Dec 31, 2021 | 8.79 Mn |
| Sep 30, 2021 | 6.84 Mn |
| Jun 30, 2021 | 5.83 Mn |